Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50.
Nick FreemantleYingxin XuFlorence R WilsonPatricia GuyotChieh-I ChenSam KeepingGerasimos KonidarisKeith ChanAndreas KuznikKokuvi AtsouEmily GlowienkaJean-Francois PouliotGiuseppe GulloPetra RietschelPublished in: Therapeutic advances in medical oncology (2022)
pembrolizumab.